使用人类基因组学来验证急性缺血性中风的药物标
1Department of Emergency Medicine, Washington University School of Medicine, St. Louis, MO, USA.
概括
基因组研究,与全基因组关联研究 (GWAS) 一样,提供了一种有前途的方法,以确定急性缺血性中风 (AIS) 的有效药物标. 这一战略提高了开发新型大脑保护疗法的成功率.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 尽管对缺血性脑损伤机制进行了广泛的研究,已经确定了1000多种药物标,但没有一种脑保护药物获得了FDA对急性缺血性中风 (AIS) 的批准.
- 传统的前向翻译研究方法取得了有限的成功,需要转向反向翻译策略.
研究的目的:
- 突出人类基因组学的潜力,特别是全基因组关联研究 (GWAS),在验证现有的药物标和发现AIS的新药物标方面.
- 探索量化表型的使用,使未来的GWAS能够研究初级和二级缺血性脑损伤机制.
主要方法:
- 审查关于缺血性脑损伤机制和药物标识的现有研究.
- 对最近一项涉及6000名AIS患者的全基因组关联研究 (GWAS) 的分析,利用早期神经系统恶化/改善的表型.
- 量化表型的探索,包括护理标准的措施,用于大规模遗传关联研究.
主要成果:
- 最近的一项GWAS在AIS患者中发现了与激发毒性相关的基因,证明了GWAS在为药物标提供人类遗传支持方面的力量.
- 该研究提供了原则证明,GWAS可以确定AIS治疗的新目标.
- 在识别简单,可靠和可扩展的表型方面仍然存在挑战,这对于在缺血性脑损伤中成功使用GWAS至关重要.
结论:
- 人类基因组学,特别是GWAS,显著增加了FDA批准AIS治疗药物的可能性.
- 使用基因组学的逆转换方法对于验证药物标和提高脑保护疗法的成功率至关重要.
- 将基因组学与其他基因组学方法和反疗法相结合,为有效的AIS治疗带来了新的乐观.
相关概念视频
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...